ask="9.98"
ask_size="300"
average_daily_volume="92755"
bid="6.68"
bid_size="1000"
book_value="5.08"
change="-0.12"
change_from_200_day_moving_average="1.41"
change_from_50_day_moving_average="1.87"
change_from_52_week_high="-5.56"
change_From_52_week_low="3.53"
change_in_percent="-1.64%"
close="7.19"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-20.26M"
eps_estimate_current_year="-3.75"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="6295000"
high="7.60"
high_52_weeks="12.75"
last_trade_date="3/16/2017"
last_trade_price="7.19"
last_trade_size="201"
last_trade_time="4:00pm"
low="7.06"
low_52_weeks="3.66"
market_capitalization="96.56M"
moving_average_200_day="5.78"
moving_average_50_day="5.32"
name="Aeglea BioTherapeutics
Inc."
notes="N/A"
one_year_target_price="17.00"
open="7.30"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+24.47%"
percent_change_from_50_day_moving_average="+35.07%"
percent_change_from_52_week_high="-43.61%"
percent_change_from_52_week_low="+96.45%"
previous_close="7.31"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.44"
price_per_sales="19.77"
revenue="4.97M"
shares_outstanding="13430000"
short_ratio="0.52"
stock_exchange="NGM"
symbol="AGLE"
volume="67532"
weeks_range_52="3.66 - 12.75"
